Comparison of Skin Incision Closure Material for the Transobturator Suburethral Sling Procedure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01313754|
Recruitment Status : Completed
First Posted : March 14, 2011
Last Update Posted : January 31, 2013
|Condition or disease||Intervention/treatment||Phase|
|Pain, Postoperative Irritation (Physical) Pelvic Pain||Procedure: Vicryl Suture Procedure: Dermabond||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||160 participants|
|Intervention Model:||Single Group Assignment|
|Study Start Date :||May 2011|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||December 2012|
These patients will receive the standard monocryl suture on their right sided inguinal incision and then will receive the vicryl material on the left.
Procedure: Vicryl Suture
Vicryl suture material will be placed on the patients left sided incision.
Other Name: polyglactin 910
The patients will receive the standard monocryl suture on their right sided inguinal incision and then will receive dermabond skin glue on the left
Dermabond skin glue will be placed on the patients left sided incision.
Other Name: 2-octyl cyanoacrylate
- The level of severity of patient discomfort at their incision sites. [ Time Frame: The patients will be assessed at their second week post operative visit. ]
- Cosmesis at the incision sites [ Time Frame: The patients will be assessed at their 2nd week post operative visit ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01313754
|United States, California|
|Loma Linda University Medical Center|
|Loma Linda, California, United States, 92354|
|Principal Investigator:||Sam Siddighi, M.D.|
|Study Director:||David B Waggonner, M.D.|